rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Robert Luther Huffines

Director

Company insider

Files Form 4 as: Director, Insulet; Director, Becton, Dickinson and; Director, Eikon Therapeutics; Director, Walgreens Boots Alliance; Director, Solid Biosciences.

In numbers

Trades disclosed
39
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
5
Companies where not an officer
5
First trade
25 Jul 2018
Last trade
30 Sep 2026
Last filed
2 Oct 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
PODD InsuletDirector · Medical Devices · last 30 Sep 20260 buys · 0 sells
BDX Becton, Dickinson andDirector · Medical Devices · last 6 Aug 20260 buys · 0 sells
EIKN Eikon TherapeuticsDirector · Biotechnology · last 2 Mar 20260 buys · 0 sells
Walgreens Boots AllianceDirector · last 13 Aug 20250 buys · 0 sells
SLDB Solid BiosciencesDirector · Biotechnology · last 13 Dec 20220 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
30 Sep 2026filed 2 Oct 2026PODD InsuletMedical DevicesSEC FORM 4 Code A$23K178 at $130.47filing
6 Aug 2026filed 6 Aug 2026BDX Becton, Dickinson andoption or derivative · Medical DevicesSEC FORM 4 Code A$31K189 at $165.62filing
6 Aug 2026filed 6 Aug 2026BDX Becton, Dickinson andoption or derivative · Medical DevicesSEC FORM 4 Code A$31K189 at $165.62filing
30 Jun 2026filed 7 Jul 2026PODD InsuletMedical DevicesSEC FORM 4 Code A$23K151 at $152.25filing
30 Jun 2026filed 7 Jul 2026PODD InsuletMedical DevicesSEC FORM 4 Code A$23K151 at $152.25filing
30 Jun 2026filed 2 Jul 2026PODD InsuletMedical DevicesSEC FORM 4 Code A$23K144 at $159.79filing
30 Jun 2026filed 2 Jul 2026PODD InsuletMedical DevicesSEC FORM 4 Code A$23K144 at $159.79filing
20 May 2026filed 21 May 2026PODD InsuletMedical DevicesSEC FORM 4 Code A—1,660 at $0.00filing
20 May 2026filed 21 May 2026PODD InsuletMedical DevicesSEC FORM 4 Code A—1,660 at $0.00filing
8 May 2026filed 8 May 2026BDX Becton, Dickinson andoption or derivative · Medical DevicesSEC FORM 4 Code A$31K210 at $149.04filing
8 May 2026filed 8 May 2026BDX Becton, Dickinson andoption or derivative · Medical DevicesSEC FORM 4 Code A$31K210 at $149.04filing
31 Mar 2026filed 2 Apr 2026PODD InsuletMedical DevicesSEC FORM 4 Code A$23K111 at $209.84filing
31 Mar 2026filed 2 Apr 2026PODD InsuletMedical DevicesSEC FORM 4 Code A$23K111 at $209.84filing
2 Mar 2026filed 4 Mar 2026EIKN Eikon Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—25,873 at $0.00filing
2 Mar 2026filed 4 Mar 2026EIKN Eikon Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—25,873 at $0.00filing
4 Feb 2026filed 5 Feb 2026BDX Becton, Dickinson andoption or derivative · Medical DevicesSEC FORM 4 Code A$20K100 at $201.91filing
4 Feb 2026filed 5 Feb 2026BDX Becton, Dickinson andoption or derivative · Medical DevicesSEC FORM 4 Code A$20K100 at $201.91filing
27 Jan 2026filed 29 Jan 2026BDX Becton, Dickinson andMedical DevicesSEC FORM 4 Code A—1,098 at $0.00filing
27 Jan 2026filed 29 Jan 2026BDX Becton, Dickinson andMedical DevicesSEC FORM 4 Code A—1,098 at $0.00filing
31 Dec 2025filed 6 Jan 2026PODD InsuletMedical DevicesSEC FORM 4 Code A$14K50.813 at $284.24filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Flavia PeaseEVP & CFO · EVP & CFO at Insulet, filing Form 4 there in the last year
Jonathan Jay MazelskyDirector · Director at Insulet, filing Form 4 there in the last year
Michael FeldEVP, Chief Revenue Officer · EVP, Chief Revenue Officer at Becton Dickinson & Co, filing Form 4 there in the last year
Column Group IV GP, LP10% owner · 10% owner at Eikon Therapeutics, filing Form 4 there in the last year
Tim KutzkeyDirector and 10% owner · 10% owner at Eikon Therapeutics, filing Form 4 there in the last year